Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Secondary syringomyelia is a rare medullar disease defined as a development of a fluid-filled cavity or syrinx within the spinal cord due to blockage of CSF circulation (e.g., due to basal archnoiditis, meningeal carcinomatosis, various mass lesions), spinal cord injury (e.g., due to trauma, radiation necrosis, hemorrhage, spinal abscess), spinal dysraphism or intramedullary tumors. It presents with neuropathic pain, numbness, muscular weakness, changes in tone or spasticity or autonomic changes (hyperhidrosis, heart rate or blood pressure instability). Selective loss of pain and temperature with relative preservation of dorsal column function (touch and pressure) are classic findings.
Features include always present findings: Syringomyelia; and very common findings: Hyperintensity of MRI T2 signal of the spinal cord. 26 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Dysphonia, Difficulty walking (gait disturbance), Paresthesia |
Phenotype severity distribution: 1 always present feature, 1 very common feature, 14 common features.
No clinical trials have been registered for secondary syringomyelia.
7 publications have been identified in PubMed for secondary syringomyelia. Research spans Case Report / Case Series (71%) and Review / Meta-Analysis (29%).
Chan WC (2025). [PMID: 40396800](https://pubmed.ncbi.nlm.nih.gov/40396800/). *Acta Neurol Taiwan*. [Case Report / Case Series]
Wendling D (2025). [PMID: 39894385](https://pubmed.ncbi.nlm.nih.gov/39894385/). *Joint Bone Spine*. [Case Report / Case Series]
Pérez-Bovet J (2025). [PMID: 40955081](https://pubmed.ncbi.nlm.nih.gov/40955081/). *Can J Neurol Sci*. [Case Report / Case Series]
Na CH (2025). [PMID: 40791296](https://pubmed.ncbi.nlm.nih.gov/40791296/). *Brain Spine*. [Case Report / Case Series]
Cheng YH (2024). [PMID: 39216056](https://pubmed.ncbi.nlm.nih.gov/39216056/). *Neurol India*. [Case Report / Case Series]
Zhang W (2024). [PMID: 39435986](https://pubmed.ncbi.nlm.nih.gov/39435986/). *CNS Neurosci Ther*. [Review / Meta-Analysis]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 5:35 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Blurred vision, Nystagmus |
Lab test results | 1 | Increased CSF protein concentration |
Muscles | 1 | Fatigable weakness |
Head and neck | 1 | Facial paralysis |
Ears | 1 | Paroxysmal vertigo |
Jung JH (2024). [PMID: 39221120](https://pubmed.ncbi.nlm.nih.gov/39221120/). *Vet Med (Praha)*. [Review / Meta-Analysis]